edit-301
Editas Medicine
['ruby']
$edit initial edit-301 data from ruby trial in sickle cell disease announced all 4 ruby patients free of vaso-occlusive events since edit-301 infusion! presenting data @ #eha23 tomorrow &amp; more data by ye 2023 click the image for other blood disease events coming... 
Catalyst Calendar, Big Mover stocks to watch, & model portfolios. Database & tools to help with your biotech stock research. not investment advice. https://t.co/5njnanqtbK